scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BMCL.2003.07.022 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0960894X03008825?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0960894X03008825?httpAccept=text/xml | ||
P698 | PubMed publication ID | 14623003 |
P2093 | author name string | Upinder Singh | |
Joseph Zhou | |||
Joaquim Trias | |||
Zhengyu Yuan | |||
Charlotte Wu | |||
Stuart Lam | |||
Robert C. Gadwood | |||
Kathleen H. Mortell | |||
Sara Lopez | |||
Joe Palandra | |||
B. Raju | |||
Maria Courtney | |||
Dinesh V. Patel | |||
Wade J. Adams | |||
Mikhail F. Gordeev | |||
Gary E. Zurenko | |||
Charles W. Ford | |||
Ronda D. Schaadt | |||
Corinne J. Hackbarth | |||
Janice M. Friis | |||
Sara E. Morin | |||
P2860 | cites work | The American Journal of Surgery | Q15762745 |
Oxazolidinones: a new class of antibacterials | Q34476164 | ||
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. | Q35125132 | ||
Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen | Q40397051 | ||
Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 1. Conversion of 5-substituent on oxazolidinone | Q43580335 | ||
Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 2. Relationship between lipophilicity and antibacterial activity in 5-thiocarbonyl oxazolidinones | Q43580339 | ||
Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 3. Synthesis and evaluation of 5-thiocarbamate oxazolidinones | Q43580343 | ||
The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo | Q44129163 | ||
New resistance in Staphylococcus aureus. | Q54105150 | ||
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. | Q55067143 | ||
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group | Q69217083 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
molecular medicine | Q3523816 | ||
pharmaceutical science | Q7180763 | ||
organic chemistry | Q11351 | ||
P304 | page(s) | 4209-4212 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
P1476 | title | New antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones | |
New Antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones | |||
P478 | volume | 13 |
Q36233502 | Anti-MRSA agents: under investigation, in the exploratory phase and clinically available |
Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
Q41843930 | N-(1-Acetyl-r-7,c-9-diphenyl-4,8-dithia-1,2-diaza-spiro-[5.4]dec-2-en-3-yl)acet-amide |
Q36477466 | Peptide deformylase inhibitors |
Q51786495 | Using the ONIOM hybrid method to apply equation of motion CCSD to larger systems: benchmarking and comparison with time-dependent density functional theory, configuration interaction singles, and time-dependent Hartree-Fock. |
Search more.